Mechanical Pulmonary Valve Replacement

Area of Science:

• Cardiovascular Surgery
• Congenital Heart Disease
• Prosthetic Valves

Background:

• Pulmonary valve replacement (PVR) is increasingly common in adults with congenital heart disease.
• Tissue valves are typically used, but repeat operations are often necessary.
• Mechanical pulmonary prostheses are an option for select patients, particularly those with complex congenital diagnoses.

Purpose of the Study:

• To review the appropriateness and outcomes of mechanical pulmonary prostheses in adults with congenital heart disease.
• To evaluate the risks and benefits of mechanical valves versus tissue valves in the pulmonary position.
• To assess the impact of anticoagulation on the safety and efficacy of mechanical pulmonary valves.

Main Methods:

• Review of existing literature on mechanical pulmonary valve replacement.
• Analysis of patient populations with congenital heart disease undergoing PVR.
• Comparison of outcomes between mechanical and tissue valves, considering anticoagulation status.

Main Results:

• Mechanical valves are durable but necessitate anticoagulation, posing inherent risks.
• Conflicting reports exist on late outcomes, with some suggesting higher complication rates for bileaflet valves in the pulmonary position, often without adequate anticoagulation.
• Proper anticoagulation and monitoring are associated with low rates of thrombosis and pulmonary prosthesis dysfunction.

Conclusions:

• Mechanical pulmonary prostheses may be appropriate for adults with congenital heart disease requiring PVR, especially when repeat operations are anticipated.
• Careful patient selection and rigorous anticoagulation management are crucial for optimizing outcomes with mechanical pulmonary valves.
• Further research is needed to clarify the long-term safety and efficacy of different types of mechanical valves in the pulmonary position.